There was also a significant decrease in low-density lipoprotein (LDL)-cholesterol levels after 6 months, and non-HDL-cholesterol levels showed a tendency to decrease over the same period
It is the first PROTAC therapy approved for breast cancer and is used for patients who have progressed after at least one line of endocrine therapy
It is a significant investment, but for those who want to avoid surgery and don't mind a clinical setting, it offers a long-term way to support a refreshed appearance
To view a copy of this licence, visit About this article Cite this article Gatta, M., Dovizio, M., Milillo, C
BPC-157 shows consistent multi-model preclinical evidence for gut epithelial repair and anti-inflammatory effects, but human clinical trial data remains limited to early-stage work